Paying attention to the standardization and individualization issues in the diagnosis and treatment of hysteroscopic uterine cavity diseases

DUAN Hua

Chinese Journal of Practical Gynecology and Obstetrics ›› 2026, Vol. 42 ›› Issue (1) : 35-40.

PDF(1045 KB)
PDF(1045 KB)
Chinese Journal of Practical Gynecology and Obstetrics ›› 2026, Vol. 42 ›› Issue (1) : 35-40. DOI: 10.19538/j.fk2026010109

Paying attention to the standardization and individualization issues in the diagnosis and treatment of hysteroscopic uterine cavity diseases

Author information +
History +

Abstract

Uterine cavity diseases have a serious impact on women's reproductive function and physiological health,and have become an increasingly important topic of concern in gynecological clinical practice,fertility regulation,and assisted reproductive technology. Hysteroscopy is performed through natural channels for direct diagnosis and minimally invasive treatment of uterine cavity diseases. It is widely used in the diagnosis and treatment of various uterine cavity occupying lesions,endometrial lesions,uterine injury diseases,uterine malformations,and early endometrial malignant tumors due to its precise positioning,unlikelihood in missing small lesions,effective protection of normal endometrium and muscle wall tissue while removing lesions,achieving the goal of preserving organs and protecting functions. It is known as a minimally invasive method and standard procedure for the diagnosis and treatment of uterine cavity diseases. In recent years,with the increasing attention to uterine cavity diseases and the development of uterine cavity reconstruction surgery,how to control the standardization of clinical diagnosis and treatment to promote it in an orderly manner,pay attention to individualized surgical choices for different populations,perform perioperative management,and reduce surgical complications has become an urgent problem to be solved in clinical practice.

Key words

uterine cavity diseases / diagnosis and treatment / standardization / individualization

Cite this article

Download Citations
DUAN Hua. Paying attention to the standardization and individualization issues in the diagnosis and treatment of hysteroscopic uterine cavity diseases[J]. Chinese Journal of Practical Gynecology and Obstetrics. 2026, 42(1): 35-40 https://doi.org/10.19538/j.fk2026010109

References

[1]
郎景和, 张晓东. 妇产科临床解剖学[M]. 2版. 山东: 山东科学技术出版社,2020:212-216.
[2]
汪沙, 段华, 沈雪, 等. 子宫腺肌病子宫内膜-肌层交界区平滑肌细胞中Lin28表达及对细胞增殖影响研究[J]. 中国实用妇科与产科杂志, 2020, 36(12):1184-1187. DOI:10.19538/j.fk2020120114.
[3]
Carbonnel M, Pirtea P, de Ziegler D, et al. Uterine factors in recurrent pregnancy losses[J]. Fertil Steril, 2021, 115(3):538-545. DOI:10.1016/j.fertnstert.2020.12.003.
[4]
朱颖军, 杨依楠. 子宫腔炎症性疾病病理学诊断标准与治疗进展[J]. 中国实用妇科与产科杂志, 2025, 41(3):273-277. DOI:10.19538/j.fk2025030104.
[5]
Dreisler E, Kjer JJ. Asherman's syndrome:current perspectives on diagnosis and management[J]. Int J Womens Health, 2019, 11:191-198. DOI:10.2147/IJWH.S165474.
[6]
Nijkang NP, Anderson L, Markham R, et al. Endometrial polyps: Pathogenesis,sequelae and treatment[J]. SAGE Open Med, 2019,7:2050312119848247. DOI:10.1177/2050312119848247.
[7]
Bosteels J, van Wessel S, Weyers S, et al. Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities[J]. Cochrane Database Syst Rev, 2018, 12(12):CD009461. DOI:10.1002/14651858.CD009461.pub4.
[8]
Pîrlog LM, Pătrăscanu AA, Ona MD, et al. HOXA10 and HOXA11 in human endometrial benign disorders: unraveling molecular pathways and their impact on reproduction[J]. Biomolecules, 2025, 15(4):563. DOI:10.3390/biom15040563.
[9]
Jansen FW, Vredevoogd CB, van Ulzen K, et al. Complications of hysteroscopy: a prospective,multicenter study[J]. Obstet Gynecol, 2000, 96(2):266-270. DOI:10.1016/s0029-7844(00)00865-6.
[10]
Aas-Eng MK, Langebrekke A, Hudelist G. Complications in operative hysteroscopy - is prevention possible?[J]. Acta Obstet Gynecol Scand, 2017, 96(12):1399-1403. DOI:10.1111/aogs.13209.
[11]
中华医学会妇产科学分会妇科内镜学组. 中国宫腔镜诊断与手术临床实践指南(2023版)[J]. 中华妇产科杂志, 2023, 58(4):241-251. DOI:10.3760/cma.j.cn112141-20221230-00791.
[12]
Wortman M, Daggett A, Ball C. Operative hysteroscopy in an office-based surgical setting: review of patient safety and satisfaction in 414 cases[J]. J Minim Invasive Gynecol, 2013, 20(1):56-63. DOI:10.1016/j.jmig.2012.08.778.
[13]
段华, 甘露. 宫腔粘连子宫腔整复手术质量控制[J]. 中国实用妇科与产科杂志, 2022, 38(1):36-40. DOI:10.19538/j.fk2022010110.
[14]
世界中医药学会妇科专业委员会, 中国医师协会妇产科医师分会宫腔镜工作组, 全国卫生产业企业管理协会妇科智能诊疗分会.宫腔粘连中西医结合诊疗中国专家共识(2024年版)[J]. 中国实用妇科与产科杂志, 2024, 40(8):819-825. DOI:10.19538/j.fk2024080111.
[15]
段华, 甘露. 子宫内膜损伤与修复存在的问题和规范化管理[J]. 中国实用妇科与产科杂志, 2022, 38(9):865-868. DOI:10.19538/j.fk2022090101.
[16]
李博涵, 段华. 子宫内膜损伤子宫腔结构异常的诊治与生育功能评估[J]. 中国实用妇科与产科杂志, 2025, 41(3):284-289. DOI:10.19538/j.fk2025030107.
[17]
Lasmar RB, Xinmei Z, Indman PD, et al. Feasibility of a new system of classification of submucous myomas:a multicenter study[J]. Fertil Steril, 2011, 95(6):2073-2077. DOI:10.1016/j.fertnstert.2011.01.147.
[18]
Bettocchi S, Ceci O, Vicino M, et al. Diagnostic inadequacy of dilatation and curettage[J]. Fertil Steril, 2001, 75(4):803-805. DOI:10.1016/s0015-0282(00)01792-1.
[19]
Goldstein SR. Modern evaluation of the endometrium[J]. Obstet Gynecol, 2010, 116(1):168-176. DOI:10.1097/AOG.0b013e3181dfd557.
[20]
中华医学会妇产科学分会妇科内镜学组, 中国民族卫生协会女性健康与生殖疾病管理分会,北京医学会妇科内镜学分会. 宫腔镜子宫内膜癌形态特征在保留生育功能治疗中作用的中国专家共识[J]. 中华妇产科杂志, 2025, 60(2):83-93. DOI:10.3760/cma.j.cn112141-20250106-00012.
[21]
Clark TJ, Voit D, Gupta JK, et al. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia:a systematic quantitative review[J]. JAMA, 2002, 288(13):1610-1621. DOI:10.1001/jama.288.13.1610.
[22]
Rodolakis A, Scambia G, Planchamp F, et al. ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma[J]. Hum Reprod Open, 2023, 2023(1): hoac057. DOI:10.1093/hropen/hoac057.
[23]
Di Spiezio Sardo A, De Angelis MC, Della Corte L, et al. Should endometrial biopsy under direct hysteroscopic visualization using the grasp technique become the new gold standard for the preoperative evaluation of the patient with endometrial cancer?[J]. Gynecol Oncol, 2020, 158(2):347-353. DOI:10.1016/j.ygyno.2020.05.012.
[24]
张颖, 段华. 宫腔镜在子宫内膜癌高危因素评估中的应用进展[J]. 首都医科大学学报, 2021, 42(2):214‑218. DOI: 10.3969/j.issn.1006‑7795.2021.02.009.
[25]
中华医学会妇产科学分会妇科内镜学组. 宫腔镜手术子宫颈预处理临床实践指南[J]. 中华妇产科杂志, 2020, 55(12):813-818. DOI:10.3760/cma.j.cn112141-20200828-00677.
[26]
杨孜, 段华, 金力. 卡前列甲酯临床应用专家共识(2020年版)[J]. 中国实用妇科与产科杂志, 2020, 36(11):1091-1097. DOI:10.19538/j.fk2020110114.
[27]
Al-Fozan H, Firwana B, Al Kadri H, et al. Preoperative ripening of the cervix before operative hysteroscopy[J]. Cochrane Database Syst Rev, 2015, 2015(4): CD005998. DOI:10.1002/14651858.CD005998.pub2.
[28]
段华, 郝敏, 王素敏, 等. 卡前列甲酯用于宫腔镜检查子宫颈预处理的多中心临床研究[J]. 中华妇产科杂志, 2018, 53(9):602-607. DOI:10.3760/cma.j.issn.0529-567x.2018.09.004.
[29]
Muzii L, Boni T, Bellati F, et al. GnRH analogue treatment before hysteroscopic resection of submucous myomas:a prospective,randomized,multicenter study[J]. Fertil Steril, 2010, 94(4):1496-1499. DOI:10.1016/j.fertnstert.2009.05.070.
[30]
孙馥箐, 段华. 宫腔镜治疗黏膜下子宫肌瘤内膜保护问题的研究进展[J]. 中国计划生育和妇产科, 2018, 10(11):23-27. DOI:10.3969/j.issn.1674-4020.2018.11.06.
[31]
Kresowik JD, Syrop CH, Van Voorhis BJ, et al. Ultrasound is the optimal choice for guidance in difficult hysteroscopy[J]. Ultrasound Obstet Gynecol, 2012, 39(6):715-718. DOI:10.1002/uog.11072.
[32]
Fan Z, Li H, Hu R, et al. Fertility-preserving treatment in young women with grade 1 presumed stage IA endometrial adenocarcinoma: a meta-analysis[J]. Int J Gynecol Cancer, 2018, 28(2):385-393. DOI:10.1097/IGC.0000000000001164.
[33]
彭燕蓁, 汪沙, 甘露, 等. CSGE与AFS宫腔粘连评分标准临床应用比较研究[J]. 中华妇产科杂志, 2023, 58(3):185-190. DOI:10.3760/cma.j.cn112141-20221207-00743.

Footnotes

利益冲突 作者声明不存在利益冲突

PDF(1045 KB)

Accesses

Citation

Detail

Sections
Recommended

/